4 Small-Cap Stocks Under The Spotlight – SUD, MSB, PRZ And AUQ

To some investors, small-cap stocks are likely to make them think twice unless they have the appetite for risk. The small-cap stocks are exposed to volatility and likely to lose money when compared to mid- and large-cap stocks. Their comparatively small valuation may reflect their businesses not being time-tested or profitable. However, some small-cap stocks can offer long-term growth potential, here are four stocks currently under the spotlight. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

SUDA PHARMACEUTICALS LTD (ASX: SUD) – The company has entered into an exclusive license agreement with a wholly owned subsidiary of Mitsubishi Tanabe Pharma Corporation as it continues to expand its coverage of ZolpiMist. The company is expected to receive milestone and option payments up to US$880,000 with an upfront fee of US$100,000. To improve the lifestyle and health of the global community the company is revolutionizing drug delivery by providing high-quality, new, innovative, oromucosal spray pharmaceutical products. The stock price is $0.006 which has gone up by 20% on the new announcement. The market capitalization at the current price is $15.49 million.

MESOBLAST LIMITED (ASX: MSB) – Mesoblast estimates the annual peak sales in the United States and EU5 for aGVHD to be approximately $US700 million. Through its strategic transactions the company has strengthened its cash position. Eligible to receive additional milestones and royalties Mesoblast received US$40 million on closing. In the first quarter FY2019 as compared to 2018 revenue increased by the US $10.5 million. On closing of the strategic cardiovascular partnership with Tasly, cash on hand to be received in October 2018 is US$40 million. The stock price is $1.070 which is down by 1.382% is near a 52-week low.

PARAZERO LIMITED (ASX: PRZ) – The company is delighted to announce Michael Huerta to its advisory board who was a former USA FAA Administrator. The revenue from ordinary activities declined from $289,318 in 2017 to $288,471 in 2018. The loss of the group amounted to US$1,481,511, for the half-year ended 30 June 2018. The company raised A$5M, and official Quotation of the securities commenced on 22 June 2018 and was admitted to the official List on ASX on 14 June 2018. The company has enough cash reserves of $3.48 million with no or zero debt. The stock price is $0.140 which is up by 16.667% on the appointment of a new board member.

ALARA RESOURCES LIMITED (ASX: AUQ) – A member of the Al Tasnim Group, a leading Omani construction, and infrastructure business has executed a share sale and purchase agreement. Through its subsidiary, Alara Oman Operations Pty Ltd has agreed to sell 19% of its 70% shareholding for OMR 3 million (AUD 10.7 million) in joint venture company Al Hadeetha Resources LLC. The Company’s cash position at 30 June 2018 was A$3.3 million as compared to 30 June 2017 of A$1.9 million. For financial year end 2018 total shareholder return was 107%. The stock price is $0.023 which is up by 15% on the back of expansion. The market capitalization at current market price is $14.47 million.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report